Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products.
The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac – Diabetic medicines, and cosmocare products.
Mono Pharmacare works with contract manufacturers to manufacture pharmaceutical products to sell them under their brand name DLS Export. The company acquired DLS Export in 2022, for an aggregate consideration of ₹ 609 lakhs, in order to grow its product portfolio in selected therapeutic areas.
As on February 28, 2023, the company has over 168 pharmaceutical companies as their distributors and stockists and also, and served over 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
Mono Pharmacare IPO Details
Mono Pharmacare IPO is a Book Built Issue. The IPO total issue size is Rs 14.84 Cr. The Mono Pharmacare IPO price is ₹26 to ₹28 per share. The IPO will list on NSE SME.
| IPO Date | Aug 28, 2023 to Aug 30, 2023 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹26 to ₹28 per share |
| Lot Size | 4000 Shares |
| Total Issue Size | 5,300,000 shares (aggregating up to ₹14.84 Cr) |
| Fresh Issue | 5,300,000 shares (aggregating up to ₹14.84 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 12,368,564 |
| Share holding post issue | 17,668,564 |
| Market Maker portion | 276,000 shares Rikhav Securities |
Mono Pharmacare IPO Reservation
Mono Pharmacare IPO a total of 5,300,000 shares are offered. QIB: 500,000 (9.43%), RII: 2,264,000 (42.72%), NII: 2,260,000 (42.64%).
| Anchor Investor Shares Offered | – |
| Market Maker Shares Offered | 276,000 (5.21%) |
| QIB Shares Offered | 500,000 (9.43%) |
| NII (HNI) Shares Offered | 2,260,000 (42.64%) |
| Retail Shares Offered | 2,264,000 (42.72%) |
| Total Shares Offered | 5,300,000 (100%) |
Mono Pharmacare IPO Timetable (Tentative)
Mono Pharmacare IPO opens on Aug 28, 2023, and closes on Aug 30, 2023.
| IPO Open Date | Monday, 28 August 2023 |
| IPO Close Date | Wednesday, 30 August 2023 |
| Basis of Allotment | Monday, 4 September 2023 |
| Initiation of Refunds | Tuesday, 5 September 2023 |
| Credit of Shares to Demat | Wednesday, 6 September 2023 |
| Listing Date | Thursday, 7 September 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Aug 30, 2023 |
Mono Pharmacare IPO Lot Size
The minimum lot size of this Mono Pharmacare IPO is 4000 shares required is ₹112,000.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹112,000 |
| Retail (Max) | 1 | 4000 | ₹112,000 |
| HNI (Min) | 2 | 8,000 | ₹224,000 |
| Lot Size Calculator |
Mono Pharmacare IPO Promoter Holding
Panilam Lakhatariya and Supal Lakhatariya are the company’s promoters.
| Pre Issue Share Holding | 81.02% |
| Post Issue Share Holding |
Company Financials
| Period Ended | 31 Mar 2020 | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 871.70 | 1,122.46 | 1,438.31 | 6,257.39 |
| Revenue | 1,168.90 | 2,837.83 | 3,710.27 | |
| Profit After Tax | 1.99 | 9.51 | 35.09 | |
| Net Worth | 201.92 | 369.58 | 427.57 | |
| Reserves and Surplus | 131.71 | |||
| Total Borrowing | 633.46 | 608.03 | 643.93 |
Amount in ₹ Lakhs
Key Performance Indicator
| KPI | Values |
|---|---|
| Market Cap (₹ Cr.) | 49.47 |
| ROE | 9.01% |
| ROCE | 10.34% |
| Debt/Equity | 2.92 |
| EPS (Rs) | 1.99 |
| RoNW | 9.01% |
Check Mono Pharmacare IPO Peer Comparison here.
Objects of the Issue
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
- To meet the working capital requirements,
- General corporate purposes, and
- To meet the issue expenses.
Mono Pharmacare IPO Review (May apply)
[Dilip Davda] The company is a distributor for many giant pharma companies and has been doing well for the reported periods. Based on FY23 earnings, the issue appears aggressively priced. Well-informed investors may park funds for the medium to long-term rewards. Read detail review…
Mono Pharmacare IPO Subscription Status (Bidding Detail)
The Mono Pharmacare IPO is subscribed 0.88 times on Aug 28, 2023 2:49:00 PM. The public issue subscribed 1.98 times in the retail category, 0.00 times in the QIB category, and 0.10 times in the NII category. Check Day by Day Subscription Details (Live Status) Reload Subscription
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 0.00 | 5,00,000 | 0 |
| NII* | 0.10 | 22,60,000 | 2,16,000 |
| Retail | 1.98 | 22,64,000 | 44,92,000 |
| Total | 0.88 | 50,24,000 | 44,32,000 |
Total Application : 1,123 (1.98 times)
*Market Maker portion is not included to NII/HNI.
Mono Pharmacare IPO Prospectus
Company Contact Information
Mono Pharmacare Limited
1A, Krinkal Apartment Opp.
Mahalaxmi Temple, Paldi
Ahmedabad -380007
Phone: +91 99780 41356
Email: cs@monopharmacareltd.com
Website: https://monopharmacareltd.com/
Mono Pharmacare IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html